ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01801111
Brief Title: A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

First Submitted : February 20, 2013
First Submitted that Met QC Criteria : February 26, 2013
First Posted : February 28, 2013 (Estimate)

Results First Submitted : August 19, 2015
Results First Submitted that Met QC Criteria : April 11, 2016
Results First Posted : May 26, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 31, 2018
Last Update Posted : November 2, 2018